De-Extinction Supply Chain
Dillon@polymath
−10.7%
since Oct 6 · after money added
The idea
I believe de-extinction turns into a major technology within a few years, not a decade, so this take owns the public picks-and-shovels behind it rather than waiting on any single private player. It holds genome editors, ancient-DNA sequencing tools, DNA synthesis firms, and the cell-engineering companies that turn edited cells into living animals, spread across many small names instead of one bet. I keep 12% in cash to add on dips, and I'd rethink this if the science stalled or the work stayed a lab curiosity instead of scaling into a real industry.
What it owns
- Reviving an extinct species means making hundreds of precise edits to a living relative's genome, the core capability these editing companies are built around. · CRISPR TherapeuticsIt is built on the editing tool the field uses to rewrite genomes, making it a core player if editing becomes a major industry., Intellia TherapeuticsIt edits genes inside living bodies, the capability needed once revival work moves from laboratory dishes to whole animals., Beam TherapeuticsIt uses base editing to change single DNA letters without cutting the strand, enabling the precision required for many edits across a single genome., Editas MedicineIt holds foundational CRISPR patents that may generate licensing value if editing activity grows into a major industry., Prime MedicineIt does prime editing, which can swap in whole new sequences like search-and-replace, closest to what rewriting an elephant toward a mammoth actually requires., Caribou BiosciencesIt builds next-generation editing tools that go beyond standard CRISPR, positioning it to move if editing becomes a major technology fast.34%
- Species revival starts by sequencing old, degraded genomes, and these companies make the machines and kits that extract and read ancient genetic material. · IlluminaIt makes the standard sequencing machines that labs use to read both ancient and modern DNA, the default first step in any revival project., 10x GenomicsIt provides single-cell analysis tools that verify what each individual cell is doing after edits, essential for confirming a revival project worked., QiagenIt makes the extraction and prep kits that pull usable DNA from degraded ancient material, the necessary step before any sequencing can happen., Pacific BiosciencesIt makes long-read sequencing machines that piece degraded ancient genomes back together from fragments, essential for assembling extinct species DNA.22%
- Edited DNA only matters once it gets into cells that grow into living tissue, so this layer covers delivery systems, cell engineering, and scaling living material. · RepligenIt sells equipment for growing cells in volume, the infrastructure layer that any biology scaling from lab bench to industry needs., MaxCyteIt sells delivery machines that get edited DNA into cells, the physical step that most editing companies already license from it., Sana BiotechnologyIt works on making engineered cells survive inside a body, the step between a successfully edited cell and a living animal.17%
- De-extinction requires manufacturing long stretches of genome from scratch, and these companies print synthetic DNA to order at scale. · Twist BioscienceIt prints synthetic DNA to order at scale, the manufacturing step that turns a sequenced genome into usable genetic material., Ginkgo BioworksIt runs a foundry for engineering cells, the kind of outsourced work a fast-growing revival industry would use rather than building in-house.15%
- Cash12%